An allogeneic NK cell line engineered to express chimeric antigen receptors A novel strategy of cellular immunotherapy against cancer

被引：2

作者：

Badoual, Cecile ^{[1
,2
]}

Bastier, Pierre-Louis ^{[1
]}

Roussel, Helene ^{[1
,2
]}

Mandavit, Marion ^{[1
]}

Tartour, Eric ^{[3
]}

机构：

[1] Univ Paris 05, Sorbonne Paris Cite, INSERM, U970, Paris, France

[2] Hop Europeen Georges Pompidou, AP HP, Serv Anat Pathol, Paris, France

[3] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Biol, Paris, France

来源：

ONCOIMMUNOLOGY | 2013年 / 2卷 / 11期

关键词：

MODIFIED T-CELLS; TRIAL;

D O I：

10.4161/onci.27156

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页数：2

共 20 条

[1]

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial [J].

Arai, S. ;

Meagher, R. ;

Swearingen, M. ;

Myint, H. ;

Rich, E. ;

Martinson, J. ;

Klingemann, H. .

CYTOTHERAPY, 2008, 10 (06) :625-632

[2]

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor [J].

Asai, Hiroaki ;

Fujiwara, Hiroshi ;

An, Jun ;

Ochi, Toshiki ;

Miyazaki, Yukihiro ;

Nagai, Kozo ;

Okamoto, Sachiko ;

Mineno, Junichi ;

Kuzushima, Kiyotaka ;

Shiku, Hiroshi ;

Inoue, Hirofumi ;

Yasukawa, Masaki .

PLOS ONE, 2013, 8 (02)

[3]

Boissel L, 2013, ONCOIMMUNOL IN PRESS

[4]

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].

Brentjens, Renier J. ;

Davila, Marco L. ;

Riviere, Isabelle ;

Park, Jae ;

Wang, Xiuyan ;

Cowell, Lindsay G. ;

Bartido, Shirley ;

Stefanski, Jolanta ;

Taylor, Clare ;

Olszewska, Malgorzata ;

Borquez-Ojeda, Oriana ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Bernal, Yvette ;

Rijo, Ivelise V. ;

Hedvat, Cyrus ;

Kobos, Rachel ;

Curran, Kevin ;

Steinherz, Peter ;

Jurcic, Joseph ;

Rosenblat, Todd ;

Maslak, Peter ;

Frattini, Mark ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)

[5]

Integrin Function in T-Cell Homing to Lymphoid and Nonlymphoid Sites: Getting There and Staying There [J].

DeNucci, Christopher C. ;

Mitchell, Jason S. ;

Shimizu, Yoji .

CRITICAL REVIEWS IN IMMUNOLOGY, 2009, 29 (02) :87-109

[6]

Trial Watch Adoptive cell transfer immunotherapy [J].

Galluzzi, Lorenzo ;

Vacchelli, Erika ;

Eggermont, Alexander ;

Fridman, Wolf Herve ;

Galon, Jerome ;

Sautes-Fridman, Catherine ;

Tartour, Eric ;

Zitvogel, Laurence ;

Kroemer, Guido .

ONCOIMMUNOLOGY, 2012, 1 (03) :306-315

[7]

Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia [J].

Grupp, Stephan A. ;

Kalos, Michael ;

Barrett, David ;

Aplenc, Richard ;

Porter, David L. ;

Rheingold, Susan R. ;

Teachey, David T. ;

Chew, Anne ;

Hauck, Bernd ;

Wright, J. Fraser ;

Milone, Michael C. ;

Levine, Bruce L. ;

June, Carl H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (16) :1509-1518

[8]

Kochenderfer JN, 2013, BLOOD IN PRESS, DOI DOI 10.1182/BL00D-2013-08-519413

[9]

Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo [J].

Milone, Michael C. ;

Fish, Jonathan D. ;

Carpenito, Carmine ;

Carroll, Richard G. ;

Binder, Gwendolyn K. ;

Teachey, David ;

Samanta, Minu ;

Lakhal, Mehdi ;

Gloss, Brian ;

Danet-Desnoyers, Gwenn ;

Campana, Dario ;

Riley, James L. ;

Grupp, Stephan A. ;

June, Carl H. .

MOLECULAR THERAPY, 2009, 17 (08) :1453-1464

[10]

Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia [J].

Porter, David L. ;

Levine, Bruce L. ;

Kalos, Michael ;

Bagg, Adam ;

June, Carl H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :725-733

← 1 2 →